MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 10.02.2026
Electromed Langfristige Verbindlichkeiten 2011-2026 | ELMD
Langfristige Verbindlichkeiten Jährlich Electromed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 8.87 K | - | - | 1.1 M | 1.16 M | 1.2 M | 1.25 M | 1.44 M | 1.67 M | 1.75 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.75 M | 8.87 K | 1.2 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.11 | -10.77 % | $ 260 M |  USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 13.94 | -0.71 % | $ 2.09 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 7.0 | 5.74 % | $ 503 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.38 | -4.58 % | $ 163 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.49 | 2.05 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 31.87 | 2.07 % | $ 1.47 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 275.33 | 2.19 % | $ 7.77 B | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 40.88 | 2.48 % | $ 6.09 K | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 75.65 | 2.97 % | $ 112 B | USA |
 |
InMode Ltd.
INMD
|
12.5 M | $ 14.0 | 0.29 % | $ 905 M | Israel |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 14.09 | -7.06 % | $ 381 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 45.89 | -0.18 % | $ 1.42 B | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.48 | 1.02 % | $ 146 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Establishment Labs Holdings
ESTA
|
53.7 M | $ 77.41 | -1.12 % | $ 2.18 B |  Costa-rica |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.53 | -0.3 % | $ 121 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 96.27 | 0.06 % | $ 13 B | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 26.14 | 0.5 % | $ 1.78 B | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.11 | -2.76 % | $ 1.28 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 11.13 | -4.01 % | $ 857 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.73 | 2.57 % | $ 39.7 M | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.4 | 6.53 % | $ 151 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 102.4 | 1.89 % | $ 1.3 B | USA |